• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成维 A 酸:结构-活性关系。

Synthetic retinoids: structure-activity relationships.

机构信息

Department of Chemistry, Durham University, South Road, Durham, DH1 3LE, UK.

出版信息

Chemistry. 2009 Nov 2;15(43):11430-42. doi: 10.1002/chem.200901952.

DOI:10.1002/chem.200901952
PMID:19821467
Abstract

Retinoid signalling pathways are involved in numerous processes in cells, particularly those mediating differentiation and apoptosis. The endogenous ligands that bind to the retinoid receptors, namely all-trans-retinoic acid (ATRA) and 9-cis-retinoic acid, are prone to double-bond isomerisation and to oxidation by metabolic enzymes, which can have significant and deleterious effects on their activities and selectivities. Many of these problems can be overcome through the use of synthetic retinoids, which are often much more stable, as well as being more active. Modification of their molecular structures can result in retinoids that act as antagonists, rather than agonists, or exhibit a large degree of selectivity for particular retinoid-receptor isotypes. Several such selective retinoids are likely to be of value as pharmaceutical agents with reduced toxicities, particularly in cancer therapy, as reagents for controlling cell differentiation, and as tools for elucidating the precise roles that specific retinoid signalling pathways play within cells.

摘要

视黄酸信号通路参与细胞中的许多过程,特别是那些介导分化和凋亡的过程。与视黄酸受体结合的内源性配体,即全反式视黄酸(ATRA)和 9-顺式视黄酸,容易发生双键异构化和代谢酶的氧化,这对视黄酸的活性和选择性有显著的有害影响。通过使用合成视黄酸可以克服许多这些问题,合成视黄酸通常更稳定,并且更具活性。对其分子结构的修饰可以得到作为拮抗剂而不是激动剂的视黄酸,或者对特定的视黄酸受体同工型表现出很大的选择性。几种这样的选择性视黄酸可能具有降低毒性的价值,特别是在癌症治疗中,作为控制细胞分化的试剂,以及作为阐明特定视黄酸信号通路在细胞内的确切作用的工具。

相似文献

1
Synthetic retinoids: structure-activity relationships.合成维 A 酸:结构-活性关系。
Chemistry. 2009 Nov 2;15(43):11430-42. doi: 10.1002/chem.200901952.
2
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.人类视黄酸核受体同种型选择性的结构基础。
J Mol Biol. 2000 Sep 8;302(1):155-70. doi: 10.1006/jmbi.2000.4032.
3
Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.类视黄醇X受体和视黄酸受体特异性类视黄醇对人宫颈外膜上皮细胞系增殖和分化的差异调节
Cell Growth Differ. 1996 Apr;7(4):521-30.
4
Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.维甲酸X受体特异性类视黄醇抑制维甲酸受体特异性类视黄醇提高人宫颈外膜上皮细胞中胰岛素样生长因子结合蛋白-3水平的能力。
Cancer Res. 1996 Apr 15;56(8):1794-9.
5
Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.构象明确的6-s-反式维甲酸类似物。3. 核受体结合、转录活性和癌症化学预防活性的构效关系。
J Med Chem. 1996 Sep 13;39(19):3625-35. doi: 10.1021/jm9603126.
6
Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.维甲酸受体亚型选择性激动剂和拮抗剂工程化的结构基础。
Chem Biol. 1999 Aug;6(8):519-29. doi: 10.1016/S1074-5521(99)80084-2.
7
Design of selective nuclear receptor modulators: RAR and RXR as a case study.选择性核受体调节剂的设计:以视黄酸受体(RAR)和视黄酸X受体(RXR)为例
Nat Rev Drug Discov. 2007 Oct;6(10):811-20. doi: 10.1038/nrd2398.
8
Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.类视黄醇与视黄酸受体α的结合亲和力与类视黄醇对雌激素受体阳性MCF-7乳腺癌细胞生长抑制作用的相关性。
Cancer Res. 1995 Oct 1;55(19):4446-51.
9
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.鉴定出对人头颈部鳞状细胞癌细胞生长具有强效抑制作用的受体选择性类视黄醇。
Clin Cancer Res. 2000 Apr;6(4):1563-73.
10
RAR and RXR modulation in cancer and metabolic disease.癌症与代谢性疾病中的视黄酸受体(RAR)和视黄酸X受体(RXR)调节
Nat Rev Drug Discov. 2007 Oct;6(10):793-810. doi: 10.1038/nrd2397.

引用本文的文献

1
Structure-Activity Relationships and Therapeutic Applications of Retinoids in View of Potential Benefits from Drug Repurposing Process.从药物重新利用过程的潜在益处看类视黄醇的构效关系及治疗应用
Biomedicines. 2024 May 10;12(5):1059. doi: 10.3390/biomedicines12051059.
2
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα.WYC-209 通过 RARα 下调 WNT4 抑制 GC 恶性进展。
Cancer Biol Ther. 2024 Dec 31;25(1):2299288. doi: 10.1080/15384047.2023.2299288. Epub 2024 Jan 4.
3
Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies.
基于药效团的虚拟筛选、分子对接和分子动力学模拟研究发现新型 RARα 激动剂。
PLoS One. 2023 Aug 24;18(8):e0289046. doi: 10.1371/journal.pone.0289046. eCollection 2023.
4
Dysregulated Retinoic Acid Signaling in the Pathogenesis of Pseudoexfoliation Syndrome.视黄酸信号通路失调在假性剥脱综合征发病机制中的作用。
Int J Mol Sci. 2022 May 26;23(11):5977. doi: 10.3390/ijms23115977.
5
All--retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells.全反式维甲酸通过诱导活性氧(ROS)诱导RARB依赖的细胞凋亡,并通过下调胆管癌细胞中的NRF2增强顺铂敏感性。
Oncol Lett. 2022 Jun;23(6):179. doi: 10.3892/ol.2022.13299. Epub 2022 Apr 14.
6
Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.基于 TCGA 数据库和生物信息学分析的头颈部鳞状细胞癌中 miR-21-5p 关键靶基因及通路研究。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221081245. doi: 10.1177/15330338221081245.
7
Synthetic Retinoids as Potential Therapeutics in Prostate Cancer-An Update of the Last Decade of Research: A Review.合成维甲酸类药物作为前列腺癌潜在治疗药物的研究进展:十年回顾。
Int J Mol Sci. 2021 Sep 29;22(19):10537. doi: 10.3390/ijms221910537.
8
Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review.新型 RARα 和 RARβ 激动剂的设计:口服生物利用度药物的进展。一篇综述。
Bioorg Med Chem. 2020 Oct 15;28(20):115664. doi: 10.1016/j.bmc.2020.115664. Epub 2020 Jul 29.
9
Site-Selective Nitrene Transfer to Conjugated Olefins Directed by Oxazoline Peptide Ligands.恶唑啉肽配体导向的向共轭烯烃的位点选择性氮宾转移反应
Adv Synth Catal. 2020 Jan 23;362(2):289-294. doi: 10.1002/adsc.201900631.
10
Photoactivated cell-killing involving a low molecular weight, donor-acceptor diphenylacetylene.涉及一种低分子量供体-受体二苯乙炔的光活化细胞杀伤作用。
Chem Sci. 2019 Mar 21;10(17):4673-4683. doi: 10.1039/c9sc00199a. eCollection 2019 May 7.